Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromosomes, Human, Pair 12 | 37 | 2006 | 462 | 2.220 |
Why?
|
Genes, APC | 26 | 2013 | 159 | 2.160 |
Why?
|
Noonan Syndrome | 11 | 2014 | 122 | 1.690 |
Why?
|
Chromosome Mapping | 90 | 2013 | 4740 | 1.590 |
Why?
|
Adenomatous Polyposis Coli Protein | 17 | 2013 | 188 | 1.360 |
Why?
|
Chromosomes, Human, Pair 22 | 17 | 2011 | 351 | 1.140 |
Why?
|
Recombination, Genetic | 23 | 2004 | 1586 | 1.090 |
Why?
|
Intestinal Neoplasms | 10 | 2013 | 319 | 0.960 |
Why?
|
Genetics, Medical | 5 | 2013 | 338 | 0.960 |
Why?
|
Adenomatous Polyposis Coli | 13 | 2009 | 224 | 0.910 |
Why?
|
Mutation | 68 | 2019 | 29786 | 0.890 |
Why?
|
Hybrid Cells | 65 | 2013 | 441 | 0.860 |
Why?
|
SOS1 Protein | 4 | 2010 | 41 | 0.830 |
Why?
|
DNA Repair | 22 | 2011 | 2046 | 0.770 |
Why?
|
DNA Mutational Analysis | 22 | 2015 | 4185 | 0.710 |
Why?
|
Genome, Human | 20 | 2018 | 4420 | 0.700 |
Why?
|
Disease Models, Animal | 35 | 2017 | 18034 | 0.690 |
Why?
|
Genes | 44 | 2006 | 1893 | 0.660 |
Why?
|
Base Pair Mismatch | 13 | 2011 | 97 | 0.620 |
Why?
|
Neoplasms | 25 | 2023 | 21696 | 0.600 |
Why?
|
DiGeorge Syndrome | 9 | 2013 | 177 | 0.600 |
Why?
|
Mutagenesis, Site-Directed | 5 | 2017 | 1723 | 0.590 |
Why?
|
Mice | 167 | 2017 | 81201 | 0.580 |
Why?
|
Colonic Neoplasms | 10 | 2012 | 2542 | 0.540 |
Why?
|
T-Box Domain Proteins | 5 | 2011 | 471 | 0.530 |
Why?
|
DNA Mismatch Repair | 5 | 2015 | 426 | 0.530 |
Why?
|
Abnormalities, Multiple | 16 | 2006 | 1416 | 0.530 |
Why?
|
DNA-Binding Proteins | 29 | 2013 | 9647 | 0.520 |
Why?
|
Base Sequence | 45 | 2018 | 12797 | 0.510 |
Why?
|
Chromosome Deletion | 15 | 2014 | 1401 | 0.500 |
Why?
|
Pharmacogenetics | 4 | 2011 | 674 | 0.500 |
Why?
|
Mice, Transgenic | 24 | 2013 | 9735 | 0.490 |
Why?
|
Mice, Mutant Strains | 20 | 2010 | 1865 | 0.470 |
Why?
|
Colorectal Neoplasms | 17 | 2019 | 6773 | 0.470 |
Why?
|
Animals | 196 | 2017 | 168768 | 0.460 |
Why?
|
Gene Expression Regulation, Neoplastic | 18 | 2018 | 8432 | 0.450 |
Why?
|
Molecular Sequence Data | 47 | 2014 | 18111 | 0.450 |
Why?
|
Molecular Biology | 1 | 2017 | 596 | 0.440 |
Why?
|
Genomics | 12 | 2022 | 5717 | 0.430 |
Why?
|
Cytoskeletal Proteins | 13 | 2016 | 1364 | 0.430 |
Why?
|
Genetic Markers | 23 | 2010 | 2634 | 0.420 |
Why?
|
Transfection | 17 | 2009 | 5895 | 0.420 |
Why?
|
Personal Health Services | 1 | 2011 | 25 | 0.410 |
Why?
|
MutS Homolog 2 Protein | 10 | 2013 | 200 | 0.410 |
Why?
|
Germ-Line Mutation | 6 | 2015 | 1788 | 0.390 |
Why?
|
Gene Rearrangement | 8 | 2018 | 1179 | 0.390 |
Why?
|
DNA | 24 | 2008 | 7294 | 0.380 |
Why?
|
Protein Tyrosine Phosphatases | 5 | 2007 | 473 | 0.380 |
Why?
|
Chromosomes, Artificial, Yeast | 11 | 2000 | 118 | 0.380 |
Why?
|
Plasmids | 18 | 2008 | 2308 | 0.370 |
Why?
|
Fungal Proteins | 4 | 2002 | 912 | 0.370 |
Why?
|
Meiosis | 4 | 2008 | 339 | 0.370 |
Why?
|
Multigene Family | 11 | 2005 | 1102 | 0.370 |
Why?
|
Sequence Tagged Sites | 11 | 2001 | 94 | 0.360 |
Why?
|
Flap Endonucleases | 2 | 2007 | 19 | 0.360 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2012 | 730 | 0.350 |
Why?
|
Gene Deletion | 12 | 2016 | 2751 | 0.350 |
Why?
|
Carrier Proteins | 16 | 2016 | 5023 | 0.350 |
Why?
|
DNA-Directed DNA Polymerase | 4 | 2008 | 486 | 0.350 |
Why?
|
Keratins | 4 | 2006 | 515 | 0.350 |
Why?
|
Mice, Knockout | 35 | 2010 | 14561 | 0.340 |
Why?
|
Cecal Neoplasms | 1 | 2008 | 29 | 0.330 |
Why?
|
DNA Primers | 13 | 2008 | 2891 | 0.330 |
Why?
|
DNA, Recombinant | 7 | 1993 | 476 | 0.320 |
Why?
|
Neoplasms, Experimental | 7 | 2010 | 1276 | 0.320 |
Why?
|
Adenocarcinoma | 12 | 2016 | 6364 | 0.320 |
Why?
|
Genotype | 27 | 2014 | 12952 | 0.310 |
Why?
|
Microtubule-Associated Proteins | 5 | 2015 | 1085 | 0.310 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2009 | 137 | 0.310 |
Why?
|
Clathrin | 3 | 2013 | 267 | 0.310 |
Why?
|
Thymidine Kinase | 15 | 1991 | 290 | 0.300 |
Why?
|
Genes, ras | 7 | 2009 | 690 | 0.300 |
Why?
|
Genes, p53 | 4 | 2015 | 755 | 0.300 |
Why?
|
Sequence Analysis, DNA | 15 | 2016 | 4805 | 0.290 |
Why?
|
Retinoblastoma Protein | 2 | 2008 | 705 | 0.290 |
Why?
|
Lung Neoplasms | 7 | 2012 | 13104 | 0.290 |
Why?
|
Catechol O-Methyltransferase | 5 | 2009 | 245 | 0.290 |
Why?
|
Homozygote | 8 | 2010 | 1787 | 0.290 |
Why?
|
Cloning, Molecular | 17 | 2002 | 4320 | 0.290 |
Why?
|
Embryonic and Fetal Development | 5 | 2000 | 438 | 0.280 |
Why?
|
Mass Spectrometry | 6 | 2015 | 2204 | 0.270 |
Why?
|
Humans | 243 | 2023 | 744366 | 0.270 |
Why?
|
Medical Oncology | 2 | 2023 | 2267 | 0.270 |
Why?
|
Blood Proteins | 3 | 2011 | 1124 | 0.270 |
Why?
|
Exodeoxyribonucleases | 1 | 2007 | 180 | 0.270 |
Why?
|
Genes, Retinoblastoma | 1 | 2006 | 136 | 0.270 |
Why?
|
Mice, Inbred C57BL | 39 | 2012 | 21833 | 0.270 |
Why?
|
Saccharomyces cerevisiae Proteins | 6 | 2004 | 1887 | 0.270 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2010 | 692 | 0.270 |
Why?
|
Ultraviolet Rays | 4 | 2008 | 1060 | 0.260 |
Why?
|
Carcinoma, Medullary | 1 | 2006 | 123 | 0.260 |
Why?
|
DNA, Neoplasm | 8 | 2015 | 1758 | 0.260 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2017 | 2938 | 0.260 |
Why?
|
Heterozygote | 11 | 2011 | 2804 | 0.250 |
Why?
|
Chromosomal Instability | 3 | 2016 | 183 | 0.250 |
Why?
|
Genome | 6 | 2022 | 1807 | 0.250 |
Why?
|
Gene Dosage | 7 | 2019 | 1252 | 0.250 |
Why?
|
Alleles | 12 | 2014 | 6933 | 0.250 |
Why?
|
Carcinoma, Renal Cell | 3 | 2016 | 3143 | 0.250 |
Why?
|
beta Catenin | 9 | 2014 | 1059 | 0.250 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 5 | 2011 | 379 | 0.240 |
Why?
|
Sulindac | 4 | 2009 | 29 | 0.240 |
Why?
|
History, 21st Century | 3 | 2017 | 1534 | 0.240 |
Why?
|
Nucleic Acid Hybridization | 13 | 2009 | 1375 | 0.240 |
Why?
|
Integrases | 4 | 2013 | 533 | 0.240 |
Why?
|
Nuclear Proteins | 15 | 2013 | 5856 | 0.240 |
Why?
|
Genetic Techniques | 6 | 1993 | 435 | 0.240 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 5 | 2009 | 234 | 0.240 |
Why?
|
Drug Therapy | 1 | 2007 | 497 | 0.230 |
Why?
|
Trans-Activators | 9 | 2003 | 2926 | 0.230 |
Why?
|
Neoplasm Proteins | 10 | 2016 | 3707 | 0.230 |
Why?
|
Thymus Gland | 2 | 2006 | 1267 | 0.230 |
Why?
|
Polymerase Chain Reaction | 18 | 2009 | 6171 | 0.230 |
Why?
|
Models, Genetic | 11 | 2019 | 3493 | 0.230 |
Why?
|
Multidrug Resistance-Associated Proteins | 2 | 2001 | 107 | 0.220 |
Why?
|
Gastrointestinal Tract | 2 | 2008 | 814 | 0.220 |
Why?
|
In Situ Hybridization, Fluorescence | 15 | 2007 | 2649 | 0.220 |
Why?
|
MAP Kinase Signaling System | 4 | 2017 | 1525 | 0.220 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2010 | 5223 | 0.220 |
Why?
|
DNA, Single-Stranded | 4 | 1989 | 355 | 0.220 |
Why?
|
Proteome | 5 | 2013 | 1798 | 0.220 |
Why?
|
Genes, Neoplasm | 5 | 2018 | 376 | 0.210 |
Why?
|
Phenotype | 31 | 2015 | 16367 | 0.210 |
Why?
|
Gastrointestinal Neoplasms | 6 | 2006 | 990 | 0.210 |
Why?
|
Point Mutation | 4 | 2008 | 1624 | 0.210 |
Why?
|
History, 20th Century | 3 | 2017 | 2740 | 0.210 |
Why?
|
Sirolimus | 1 | 2010 | 1565 | 0.210 |
Why?
|
Genetic Linkage | 16 | 2007 | 2421 | 0.210 |
Why?
|
Simian virus 40 | 6 | 1984 | 297 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2007 | 15520 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 3595 | 0.200 |
Why?
|
Oligonucleotide Array Sequence Analysis | 13 | 2012 | 3921 | 0.200 |
Why?
|
Smad2 Protein | 5 | 2006 | 156 | 0.200 |
Why?
|
Microfilament Proteins | 2 | 2009 | 1152 | 0.200 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2017 | 2110 | 0.200 |
Why?
|
Disease Progression | 10 | 2019 | 13286 | 0.200 |
Why?
|
Phosphotransferases | 11 | 1991 | 308 | 0.200 |
Why?
|
Haptoglobins | 2 | 2017 | 165 | 0.200 |
Why?
|
Repetitive Sequences, Nucleic Acid | 7 | 2002 | 798 | 0.200 |
Why?
|
Endodeoxyribonucleases | 1 | 2002 | 165 | 0.200 |
Why?
|
Glucose Transporter Type 4 | 2 | 2013 | 250 | 0.190 |
Why?
|
Globins | 6 | 1987 | 416 | 0.190 |
Why?
|
ras Proteins | 4 | 2014 | 1060 | 0.190 |
Why?
|
Gene Expression Profiling | 13 | 2017 | 9445 | 0.190 |
Why?
|
Lymphatic Vessels | 3 | 2011 | 353 | 0.190 |
Why?
|
Simplexvirus | 6 | 1991 | 803 | 0.190 |
Why?
|
Mood Disorders | 1 | 2007 | 1106 | 0.190 |
Why?
|
Genomic Instability | 4 | 2010 | 695 | 0.180 |
Why?
|
Haplotypes | 8 | 2007 | 2779 | 0.180 |
Why?
|
Gene Targeting | 4 | 2002 | 880 | 0.180 |
Why?
|
Gastrula | 1 | 1999 | 84 | 0.170 |
Why?
|
Exons | 6 | 2016 | 2439 | 0.170 |
Why?
|
Clathrin Heavy Chains | 3 | 2013 | 26 | 0.170 |
Why?
|
Trinucleotide Repeat Expansion | 3 | 2012 | 243 | 0.170 |
Why?
|
Myosin Heavy Chains | 2 | 1999 | 414 | 0.170 |
Why?
|
Genomic Structural Variation | 1 | 2019 | 64 | 0.170 |
Why?
|
Transforming Growth Factor beta | 5 | 2013 | 2007 | 0.170 |
Why?
|
Translocation, Genetic | 11 | 1997 | 1420 | 0.170 |
Why?
|
Transcription Factors | 12 | 2013 | 12207 | 0.170 |
Why?
|
Apoptosis | 14 | 2013 | 9724 | 0.170 |
Why?
|
Intracellular Signaling Peptides and Proteins | 8 | 2016 | 2916 | 0.170 |
Why?
|
Fibroblasts | 18 | 2009 | 4162 | 0.170 |
Why?
|
Chromosomes, Human, 6-12 and X | 10 | 1980 | 80 | 0.160 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 5 | 2011 | 2282 | 0.160 |
Why?
|
Microsatellite Repeats | 7 | 2006 | 802 | 0.160 |
Why?
|
Lymphoma | 5 | 2005 | 1877 | 0.160 |
Why?
|
Chromosomes, Human, 13-15 | 10 | 1977 | 52 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2017 | 2504 | 0.160 |
Why?
|
Signal Transduction | 17 | 2017 | 23404 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 11 | 2009 | 2917 | 0.160 |
Why?
|
Telomerase | 2 | 2014 | 730 | 0.160 |
Why?
|
Software | 3 | 2008 | 4441 | 0.150 |
Why?
|
Endometrial Neoplasms | 4 | 2014 | 1351 | 0.150 |
Why?
|
Muscle Fibers, Fast-Twitch | 1 | 1997 | 69 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 9 | 2017 | 2943 | 0.150 |
Why?
|
DNA Copy Number Variations | 6 | 2019 | 1941 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 15 | 2015 | 17446 | 0.150 |
Why?
|
Gene Fusion | 2 | 2022 | 371 | 0.150 |
Why?
|
Patient Participation | 1 | 2007 | 1457 | 0.150 |
Why?
|
Proteomics | 3 | 2011 | 3638 | 0.150 |
Why?
|
Pituitary Neoplasms | 1 | 2006 | 1345 | 0.150 |
Why?
|
Cell Line | 33 | 2009 | 16000 | 0.150 |
Why?
|
Wnt Proteins | 2 | 2013 | 721 | 0.150 |
Why?
|
Antineoplastic Agents | 7 | 2013 | 13693 | 0.150 |
Why?
|
Transformation, Genetic | 4 | 1989 | 192 | 0.150 |
Why?
|
RNA, Neoplasm | 2 | 2013 | 769 | 0.150 |
Why?
|
Female | 98 | 2017 | 380193 | 0.150 |
Why?
|
Schizophrenia | 9 | 2009 | 6882 | 0.150 |
Why?
|
Psychotic Disorders | 5 | 2007 | 3046 | 0.150 |
Why?
|
Glycoproteins | 3 | 2012 | 2266 | 0.150 |
Why?
|
Oncogene Fusion | 1 | 2017 | 99 | 0.150 |
Why?
|
Chromosomes, Human, 16-18 | 11 | 1977 | 32 | 0.140 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2013 | 957 | 0.140 |
Why?
|
Gene Amplification | 6 | 2008 | 1063 | 0.140 |
Why?
|
Computer Communication Networks | 2 | 1995 | 295 | 0.140 |
Why?
|
Restriction Mapping | 8 | 1998 | 878 | 0.140 |
Why?
|
Nobel Prize | 1 | 2017 | 49 | 0.140 |
Why?
|
Neurotensin | 1 | 1996 | 61 | 0.140 |
Why?
|
Chromosome Aberrations | 14 | 2013 | 1813 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 4034 | 0.140 |
Why?
|
Mutation, Missense | 7 | 2012 | 2566 | 0.140 |
Why?
|
Adenosine Triphosphatases | 4 | 2008 | 839 | 0.140 |
Why?
|
Rec A Recombinases | 1 | 1996 | 51 | 0.140 |
Why?
|
Syndrome | 11 | 2006 | 3252 | 0.140 |
Why?
|
Carcinosarcoma | 1 | 2017 | 108 | 0.140 |
Why?
|
Oligodeoxyribonucleotides | 4 | 1995 | 708 | 0.140 |
Why?
|
Protein Kinase Inhibitors | 2 | 2010 | 5534 | 0.140 |
Why?
|
Genes, Bacterial | 3 | 2005 | 1079 | 0.140 |
Why?
|
Gene Expression Regulation, Developmental | 9 | 2013 | 3617 | 0.140 |
Why?
|
Phenylalanine Hydroxylase | 1 | 1995 | 30 | 0.140 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2005 | 1265 | 0.130 |
Why?
|
Epithelial Cells | 5 | 2013 | 3690 | 0.130 |
Why?
|
Skin | 3 | 2011 | 4372 | 0.130 |
Why?
|
Cyclin D1 | 3 | 2008 | 463 | 0.130 |
Why?
|
Automation | 2 | 2008 | 584 | 0.130 |
Why?
|
Male | 89 | 2016 | 350115 | 0.130 |
Why?
|
Pancreatic Elastase | 1 | 1995 | 136 | 0.130 |
Why?
|
Polymorphism, Genetic | 6 | 2006 | 4328 | 0.130 |
Why?
|
Muscle, Skeletal | 5 | 2013 | 4925 | 0.130 |
Why?
|
Mice, Nude | 6 | 2017 | 3689 | 0.130 |
Why?
|
Genetic Engineering | 4 | 1987 | 951 | 0.130 |
Why?
|
Genetic Vectors | 8 | 1995 | 3424 | 0.130 |
Why?
|
Receptors, Cell Surface | 4 | 2000 | 2865 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2010 | 1692 | 0.130 |
Why?
|
Protein Array Analysis | 2 | 2007 | 411 | 0.130 |
Why?
|
Genes, Viral | 4 | 1984 | 718 | 0.130 |
Why?
|
Haploinsufficiency | 1 | 2016 | 328 | 0.120 |
Why?
|
Cell Survival | 5 | 2006 | 5882 | 0.120 |
Why?
|
Intestinal Mucosa | 9 | 2010 | 3037 | 0.120 |
Why?
|
Escherichia coli Proteins | 2 | 2002 | 1050 | 0.120 |
Why?
|
Interinstitutional Relations | 1 | 1995 | 241 | 0.120 |
Why?
|
Neurofibromin 1 | 2 | 2014 | 196 | 0.120 |
Why?
|
Sequence Deletion | 6 | 2008 | 1525 | 0.120 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2015 | 114 | 0.120 |
Why?
|
Conserved Sequence | 6 | 2006 | 1202 | 0.120 |
Why?
|
Anticarcinogenic Agents | 1 | 1996 | 253 | 0.120 |
Why?
|
Adenoma | 5 | 2015 | 2174 | 0.120 |
Why?
|
Germinoma | 3 | 2000 | 134 | 0.120 |
Why?
|
GRB10 Adaptor Protein | 1 | 2013 | 22 | 0.120 |
Why?
|
Amino Acid Sequence | 15 | 2009 | 13814 | 0.120 |
Why?
|
Huntington Disease | 2 | 2012 | 1124 | 0.120 |
Why?
|
Darier Disease | 3 | 1999 | 12 | 0.120 |
Why?
|
Embryo, Mammalian | 6 | 2006 | 1701 | 0.110 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2013 | 78 | 0.110 |
Why?
|
Muscular Diseases | 2 | 2013 | 555 | 0.110 |
Why?
|
Radiation Tolerance | 2 | 2005 | 486 | 0.110 |
Why?
|
Cecum | 3 | 2009 | 237 | 0.110 |
Why?
|
Pentose Phosphate Pathway | 1 | 2013 | 124 | 0.110 |
Why?
|
Cosmids | 4 | 2000 | 107 | 0.110 |
Why?
|
Gene Library | 5 | 2001 | 1074 | 0.110 |
Why?
|
Proteins | 10 | 2011 | 6100 | 0.110 |
Why?
|
Immunohistochemistry | 12 | 2010 | 11366 | 0.110 |
Why?
|
Skin Neoplasms | 4 | 2006 | 5692 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2017 | 1581 | 0.110 |
Why?
|
Contig Mapping | 3 | 2001 | 54 | 0.110 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2014 | 335 | 0.110 |
Why?
|
Thyroid Neoplasms | 1 | 2006 | 2282 | 0.110 |
Why?
|
Muscle Contraction | 1 | 1997 | 1235 | 0.110 |
Why?
|
Replication Protein A | 2 | 2010 | 52 | 0.110 |
Why?
|
Genes, Mitochondrial | 1 | 2012 | 61 | 0.110 |
Why?
|
Glioblastoma | 5 | 2015 | 3481 | 0.110 |
Why?
|
DNA, Complementary | 6 | 1997 | 2050 | 0.110 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 482 | 0.110 |
Why?
|
Repressor Proteins | 5 | 2008 | 3024 | 0.110 |
Why?
|
Colon | 5 | 2008 | 1772 | 0.100 |
Why?
|
Citric Acid Cycle | 1 | 2013 | 232 | 0.100 |
Why?
|
Genes, p16 | 1 | 2012 | 157 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2012 | 76 | 0.100 |
Why?
|
Carbohydrate Epimerases | 5 | 1976 | 46 | 0.100 |
Why?
|
Lipoproteins | 1 | 1997 | 878 | 0.100 |
Why?
|
Carcinoma, Endometrioid | 1 | 2014 | 271 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 4 | 2005 | 2850 | 0.100 |
Why?
|
DNA, Viral | 8 | 1986 | 2227 | 0.100 |
Why?
|
Carcinoembryonic Antigen | 3 | 2015 | 349 | 0.100 |
Why?
|
Cricetinae | 9 | 1996 | 2475 | 0.100 |
Why?
|
Sequence Homology, Amino Acid | 8 | 2009 | 2839 | 0.100 |
Why?
|
Face | 7 | 2006 | 994 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 8 | 2016 | 4554 | 0.100 |
Why?
|
Immunoglobulin Class Switching | 2 | 2006 | 291 | 0.100 |
Why?
|
Retroelements | 1 | 2012 | 164 | 0.100 |
Why?
|
Neostriatum | 1 | 2012 | 250 | 0.100 |
Why?
|
Frameshift Mutation | 3 | 2002 | 399 | 0.100 |
Why?
|
Muscles | 1 | 1996 | 1614 | 0.100 |
Why?
|
Beta-Globulins | 5 | 1976 | 27 | 0.100 |
Why?
|
Plasminogen Activators | 2 | 1983 | 209 | 0.100 |
Why?
|
Demyelinating Diseases | 1 | 2013 | 354 | 0.090 |
Why?
|
Genome, Bacterial | 2 | 2006 | 760 | 0.090 |
Why?
|
Pyruvate Kinase | 5 | 1976 | 189 | 0.090 |
Why?
|
Uterine Neoplasms | 2 | 2017 | 1513 | 0.090 |
Why?
|
Cathepsin B | 1 | 2010 | 82 | 0.090 |
Why?
|
Schizophrenic Psychology | 3 | 2006 | 1678 | 0.090 |
Why?
|
Mutagenesis | 4 | 2006 | 1264 | 0.090 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 257 | 0.090 |
Why?
|
Organometallic Compounds | 1 | 2014 | 665 | 0.090 |
Why?
|
Mixed Function Oxygenases | 1 | 2011 | 272 | 0.090 |
Why?
|
Mutant Proteins | 1 | 2012 | 500 | 0.090 |
Why?
|
Cyclins | 3 | 2001 | 603 | 0.090 |
Why?
|
DNA Restriction Enzymes | 6 | 1987 | 570 | 0.090 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2012 | 320 | 0.090 |
Why?
|
Chromatin | 4 | 2016 | 2933 | 0.090 |
Why?
|
Behavior, Animal | 3 | 2011 | 1881 | 0.090 |
Why?
|
Cell Division | 8 | 2007 | 4569 | 0.090 |
Why?
|
Testicular Neoplasms | 3 | 2002 | 806 | 0.090 |
Why?
|
rac GTP-Binding Proteins | 1 | 2010 | 164 | 0.090 |
Why?
|
Lymphatic System | 1 | 2011 | 252 | 0.090 |
Why?
|
Ovarian Neoplasms | 4 | 2013 | 4839 | 0.090 |
Why?
|
Genetic Variation | 6 | 2008 | 6542 | 0.090 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 1997 | 1085 | 0.090 |
Why?
|
Dystrophin-Associated Proteins | 5 | 2009 | 61 | 0.090 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2010 | 56 | 0.090 |
Why?
|
Matrix Metalloproteinases | 1 | 2012 | 391 | 0.090 |
Why?
|
Cell Line, Tumor | 7 | 2017 | 16690 | 0.090 |
Why?
|
Cells, Cultured | 16 | 2016 | 19233 | 0.090 |
Why?
|
Crosses, Genetic | 7 | 2010 | 791 | 0.090 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2009 | 25 | 0.090 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 610 | 0.090 |
Why?
|
Tooth, Supernumerary | 1 | 2009 | 8 | 0.090 |
Why?
|
Armadillo Domain Proteins | 1 | 2009 | 22 | 0.090 |
Why?
|
beta 2-Microglobulin | 5 | 1976 | 315 | 0.090 |
Why?
|
Heart Defects, Congenital | 11 | 2006 | 4583 | 0.090 |
Why?
|
Embryo Loss | 2 | 2006 | 59 | 0.090 |
Why?
|
Physical Chromosome Mapping | 4 | 2002 | 183 | 0.090 |
Why?
|
Escherichia coli | 5 | 2002 | 4217 | 0.090 |
Why?
|
ran GTP-Binding Protein | 1 | 2009 | 54 | 0.090 |
Why?
|
L-Lactate Dehydrogenase | 3 | 1975 | 424 | 0.090 |
Why?
|
Keratin-14 | 1 | 2009 | 57 | 0.080 |
Why?
|
Pedigree | 9 | 2015 | 4642 | 0.080 |
Why?
|
Saccharomyces cerevisiae | 5 | 2004 | 2751 | 0.080 |
Why?
|
Rad51 Recombinase | 3 | 2000 | 189 | 0.080 |
Why?
|
Clathrin-Coated Vesicles | 1 | 2009 | 74 | 0.080 |
Why?
|
Visual Pathways | 1 | 2013 | 565 | 0.080 |
Why?
|
Human Genome Project | 3 | 2001 | 193 | 0.080 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 670 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 2 | 2013 | 1142 | 0.080 |
Why?
|
Genes, Dominant | 1 | 1991 | 880 | 0.080 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 634 | 0.080 |
Why?
|
DNA, Bacterial | 3 | 2006 | 1465 | 0.080 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 783 | 0.080 |
Why?
|
Anemia, Sickle Cell | 1 | 2017 | 1020 | 0.080 |
Why?
|
Genetic Testing | 5 | 2008 | 3444 | 0.080 |
Why?
|
Heart | 4 | 2010 | 4464 | 0.080 |
Why?
|
Gene Silencing | 5 | 2009 | 1539 | 0.080 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2012 | 450 | 0.080 |
Why?
|
Proteoglycans | 3 | 2000 | 837 | 0.080 |
Why?
|
Pigment Epithelium of Eye | 2 | 2000 | 220 | 0.080 |
Why?
|
Algorithms | 7 | 2013 | 13882 | 0.080 |
Why?
|
Kidney Neoplasms | 2 | 2016 | 4262 | 0.080 |
Why?
|
Longevity | 2 | 2011 | 1071 | 0.080 |
Why?
|
Papillomaviridae | 1 | 2014 | 1119 | 0.080 |
Why?
|
Expressed Sequence Tags | 3 | 2006 | 255 | 0.080 |
Why?
|
Nucleic Acid Conformation | 2 | 1989 | 913 | 0.080 |
Why?
|
RNA, Messenger | 10 | 2016 | 13035 | 0.080 |
Why?
|
Quinolines | 1 | 2013 | 732 | 0.080 |
Why?
|
Milk Proteins | 1 | 2009 | 169 | 0.080 |
Why?
|
Cisplatin | 3 | 2009 | 1662 | 0.080 |
Why?
|
Cell Adhesion Molecules | 2 | 2009 | 1602 | 0.080 |
Why?
|
Cystic Fibrosis | 1 | 2017 | 1178 | 0.080 |
Why?
|
Cell Cycle Proteins | 5 | 2005 | 3464 | 0.080 |
Why?
|
X Chromosome | 2 | 1991 | 814 | 0.080 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6234 | 0.080 |
Why?
|
Genetic Association Studies | 2 | 2014 | 2703 | 0.080 |
Why?
|
Receptors, Interleukin-3 | 1 | 2007 | 30 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 1995 | 1988 | 0.080 |
Why?
|
DNA Methylation | 4 | 2014 | 4285 | 0.080 |
Why?
|
Genes, Lethal | 2 | 1999 | 242 | 0.080 |
Why?
|
Hyperplasia | 5 | 2006 | 1185 | 0.070 |
Why?
|
Chromosomes, Human | 3 | 2014 | 457 | 0.070 |
Why?
|
Mammary Glands, Animal | 1 | 2009 | 276 | 0.070 |
Why?
|
Chromosomes, Artificial, Bacterial | 3 | 2004 | 126 | 0.070 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 1 | 2007 | 39 | 0.070 |
Why?
|
Gene Expression Regulation | 9 | 2006 | 12073 | 0.070 |
Why?
|
Asparagine | 1 | 2007 | 122 | 0.070 |
Why?
|
Peptides | 4 | 2012 | 4410 | 0.070 |
Why?
|
DNA Nucleotidyltransferases | 1 | 1987 | 193 | 0.070 |
Why?
|
Imidazoles | 1 | 2013 | 1206 | 0.070 |
Why?
|
Intestine, Small | 3 | 2009 | 1240 | 0.070 |
Why?
|
Mutagenesis, Insertional | 4 | 2012 | 655 | 0.070 |
Why?
|
DNA Repair Enzymes | 3 | 2008 | 349 | 0.070 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2011 | 388 | 0.070 |
Why?
|
Microsatellite Instability | 4 | 2012 | 684 | 0.070 |
Why?
|
Membrane Proteins | 4 | 2000 | 7882 | 0.070 |
Why?
|
Hemopexin | 1 | 2006 | 33 | 0.070 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2007 | 110 | 0.070 |
Why?
|
Sensitivity and Specificity | 7 | 2015 | 14723 | 0.070 |
Why?
|
Long-Term Potentiation | 2 | 2005 | 293 | 0.070 |
Why?
|
STAT3 Transcription Factor | 1 | 2010 | 874 | 0.070 |
Why?
|
Precancerous Conditions | 5 | 2006 | 975 | 0.070 |
Why?
|
Pseudomonas | 1 | 2006 | 117 | 0.070 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2011 | 615 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2007 | 262 | 0.070 |
Why?
|
Kanamycin Kinase | 3 | 1991 | 34 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2015 | 2949 | 0.070 |
Why?
|
Lipoma | 3 | 1997 | 334 | 0.070 |
Why?
|
Databases, Protein | 1 | 2008 | 383 | 0.070 |
Why?
|
Mammals | 3 | 1996 | 1143 | 0.070 |
Why?
|
Penetrance | 1 | 2007 | 381 | 0.070 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2007 | 97 | 0.070 |
Why?
|
Cleft Palate | 5 | 1997 | 560 | 0.070 |
Why?
|
B-Lymphocytes | 4 | 2009 | 4666 | 0.070 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 1998 | 529 | 0.070 |
Why?
|
Nerve Tissue Proteins | 3 | 2012 | 4463 | 0.070 |
Why?
|
Genes, erbB-1 | 1 | 2006 | 161 | 0.070 |
Why?
|
Up-Regulation | 2 | 2013 | 4222 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2014 | 1480 | 0.070 |
Why?
|
Nucleotidyltransferases | 1 | 1987 | 220 | 0.070 |
Why?
|
Calcium, Dietary | 1 | 2008 | 526 | 0.070 |
Why?
|
Fluorescence | 1 | 2008 | 751 | 0.070 |
Why?
|
Chromans | 1 | 2005 | 122 | 0.070 |
Why?
|
Virulence | 2 | 2006 | 1333 | 0.070 |
Why?
|
Phosphoproteins | 2 | 2009 | 2441 | 0.070 |
Why?
|
Survival Analysis | 3 | 2017 | 10252 | 0.070 |
Why?
|
Genetic Diseases, Inborn | 4 | 2001 | 587 | 0.070 |
Why?
|
Morphogenesis | 3 | 2013 | 751 | 0.060 |
Why?
|
Molecular Imaging | 1 | 2012 | 828 | 0.060 |
Why?
|
Gene Expression | 6 | 2003 | 7798 | 0.060 |
Why?
|
United States | 6 | 2017 | 69872 | 0.060 |
Why?
|
Databases, Factual | 3 | 2001 | 7730 | 0.060 |
Why?
|
CpG Islands | 4 | 2019 | 1170 | 0.060 |
Why?
|
Cardiomegaly | 1 | 2008 | 620 | 0.060 |
Why?
|
Genes, Recessive | 1 | 2007 | 641 | 0.060 |
Why?
|
Tooth | 1 | 2006 | 207 | 0.060 |
Why?
|
Plasma | 1 | 2008 | 575 | 0.060 |
Why?
|
Chromosomes | 4 | 2008 | 596 | 0.060 |
Why?
|
Ataxia Telangiectasia | 1 | 2005 | 112 | 0.060 |
Why?
|
Extracellular Fluid | 1 | 2006 | 167 | 0.060 |
Why?
|
Cluster Analysis | 2 | 2015 | 2715 | 0.060 |
Why?
|
Regeneration | 1 | 2013 | 1485 | 0.060 |
Why?
|
Ouabain | 2 | 1975 | 264 | 0.060 |
Why?
|
Species Specificity | 6 | 2002 | 2478 | 0.060 |
Why?
|
Survival Rate | 5 | 2016 | 12788 | 0.060 |
Why?
|
Blotting, Southern | 3 | 2005 | 803 | 0.060 |
Why?
|
Organ Specificity | 3 | 2006 | 2008 | 0.060 |
Why?
|
Hair Follicle | 1 | 2006 | 208 | 0.060 |
Why?
|
DNA Damage | 4 | 2008 | 2432 | 0.060 |
Why?
|
Chromosomes, Human, 1-3 | 7 | 1978 | 23 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2645 | 0.060 |
Why?
|
Cell Differentiation | 8 | 2013 | 11486 | 0.060 |
Why?
|
Hexosaminidases | 5 | 1976 | 54 | 0.060 |
Why?
|
DNA Transposable Elements | 2 | 2001 | 748 | 0.060 |
Why?
|
Intelligence | 2 | 2006 | 920 | 0.060 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1970 | 0.060 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 5867 | 0.060 |
Why?
|
Brain | 6 | 2012 | 26388 | 0.060 |
Why?
|
Adult | 26 | 2015 | 214052 | 0.060 |
Why?
|
Models, Molecular | 4 | 2009 | 5451 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 868 | 0.060 |
Why?
|
Cholecalciferol | 1 | 2008 | 535 | 0.060 |
Why?
|
Cell Membrane | 3 | 2009 | 3749 | 0.060 |
Why?
|
Bipolar Disorder | 4 | 2007 | 5027 | 0.060 |
Why?
|
Intestine, Large | 1 | 2003 | 71 | 0.060 |
Why?
|
Cardiovascular Abnormalities | 2 | 2001 | 144 | 0.060 |
Why?
|
Tissue Array Analysis | 2 | 2015 | 553 | 0.060 |
Why?
|
Warfarin | 1 | 2011 | 1497 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2016 | 2455 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2011 | 2307 | 0.060 |
Why?
|
Drug Industry | 2 | 2007 | 746 | 0.060 |
Why?
|
Thymus Neoplasms | 1 | 2005 | 268 | 0.050 |
Why?
|
Loss of Heterozygosity | 4 | 2010 | 684 | 0.050 |
Why?
|
Moloney murine leukemia virus | 1 | 1982 | 139 | 0.050 |
Why?
|
Sulfonamides | 1 | 2012 | 1940 | 0.050 |
Why?
|
Memory, Short-Term | 1 | 2009 | 977 | 0.050 |
Why?
|
Mitosis | 3 | 2004 | 1208 | 0.050 |
Why?
|
Chromatography, Liquid | 1 | 2006 | 976 | 0.050 |
Why?
|
Cognition Disorders | 2 | 2007 | 4043 | 0.050 |
Why?
|
Blotting, Northern | 2 | 1996 | 1581 | 0.050 |
Why?
|
Thiazolidinediones | 1 | 2005 | 476 | 0.050 |
Why?
|
Adipocytes | 1 | 2009 | 1185 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2006 | 995 | 0.050 |
Why?
|
Chromosomes, Mammalian | 1 | 2002 | 151 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2002 | 127 | 0.050 |
Why?
|
DNA Replication | 3 | 2002 | 1399 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2011 | 2132 | 0.050 |
Why?
|
Lectins, C-Type | 3 | 2000 | 589 | 0.050 |
Why?
|
Pyrazoles | 1 | 2012 | 1972 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1911 | 0.050 |
Why?
|
Drug Design | 1 | 2007 | 1076 | 0.050 |
Why?
|
Liposarcoma | 2 | 2002 | 333 | 0.050 |
Why?
|
Fluorescent Dyes | 2 | 2008 | 1917 | 0.050 |
Why?
|
Base Composition | 3 | 2006 | 293 | 0.050 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2008 | 851 | 0.050 |
Why?
|
Mucins | 2 | 2002 | 564 | 0.050 |
Why?
|
Genetic Heterogeneity | 2 | 2002 | 733 | 0.050 |
Why?
|
Gastric Mucosa | 3 | 1999 | 599 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3873 | 0.050 |
Why?
|
Stem Cells | 9 | 2013 | 3567 | 0.050 |
Why?
|
Seminoma | 1 | 2002 | 139 | 0.050 |
Why?
|
Hedgehog Proteins | 1 | 2006 | 783 | 0.050 |
Why?
|
Proto-Oncogenes | 1 | 2002 | 321 | 0.050 |
Why?
|
Lectins | 3 | 2000 | 513 | 0.050 |
Why?
|
H-2 Antigens | 1 | 2001 | 366 | 0.050 |
Why?
|
Down-Regulation | 2 | 2016 | 3001 | 0.050 |
Why?
|
Glucose | 2 | 2013 | 4398 | 0.050 |
Why?
|
Saccharomycetales | 1 | 2001 | 67 | 0.050 |
Why?
|
Killer Cells, Natural | 2 | 2000 | 2133 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2725 | 0.050 |
Why?
|
MicroRNAs | 2 | 2016 | 3751 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 11525 | 0.050 |
Why?
|
Fertility | 1 | 2006 | 781 | 0.050 |
Why?
|
Neurons | 3 | 2012 | 9340 | 0.050 |
Why?
|
Myosin Light Chains | 1 | 2000 | 121 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2736 | 0.050 |
Why?
|
Addison Disease | 1 | 2000 | 48 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2008 | 1434 | 0.050 |
Why?
|
DNA, Circular | 1 | 1980 | 97 | 0.050 |
Why?
|
Cell Proliferation | 4 | 2016 | 10483 | 0.050 |
Why?
|
Neural Crest | 1 | 2002 | 275 | 0.050 |
Why?
|
Chimera | 3 | 1997 | 485 | 0.050 |
Why?
|
Cardiac Myosins | 1 | 2000 | 117 | 0.050 |
Why?
|
Myoblasts | 2 | 2013 | 238 | 0.050 |
Why?
|
Glioma | 1 | 2015 | 3401 | 0.050 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2000 | 65 | 0.050 |
Why?
|
Muscle Weakness | 2 | 2006 | 413 | 0.050 |
Why?
|
Membrane Glycoproteins | 4 | 2000 | 3771 | 0.040 |
Why?
|
Pigmentation Disorders | 1 | 2000 | 101 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2002 | 431 | 0.040 |
Why?
|
Chromosomes, Bacterial | 2 | 1999 | 282 | 0.040 |
Why?
|
Evolution, Molecular | 3 | 2006 | 1939 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 3646 | 0.040 |
Why?
|
DNA, Fungal | 1 | 2001 | 280 | 0.040 |
Why?
|
Cell Transformation, Viral | 2 | 1984 | 567 | 0.040 |
Why?
|
Receptors, Neuropeptide | 1 | 2000 | 111 | 0.040 |
Why?
|
Myxoma | 1 | 2000 | 130 | 0.040 |
Why?
|
Learning | 1 | 2009 | 1711 | 0.040 |
Why?
|
Hemoglobins | 2 | 1976 | 1532 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 2014 | 6386 | 0.040 |
Why?
|
Esophageal Achalasia | 1 | 2000 | 90 | 0.040 |
Why?
|
Transduction, Genetic | 1 | 1982 | 913 | 0.040 |
Why?
|
Protein Isoforms | 3 | 2009 | 1730 | 0.040 |
Why?
|
Mice, Inbred Strains | 3 | 2008 | 1828 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8091 | 0.040 |
Why?
|
Mitochondria | 4 | 2009 | 3514 | 0.040 |
Why?
|
Immunoglobulin Isotypes | 1 | 1999 | 158 | 0.040 |
Why?
|
Calcium-Transporting ATPases | 1 | 1999 | 123 | 0.040 |
Why?
|
Egg Proteins | 1 | 1999 | 58 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4851 | 0.040 |
Why?
|
Smad3 Protein | 3 | 2006 | 180 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2086 | 0.040 |
Why?
|
Parathyroid Glands | 1 | 2001 | 509 | 0.040 |
Why?
|
Aspirin | 1 | 2011 | 3283 | 0.040 |
Why?
|
Esterases | 2 | 1980 | 95 | 0.040 |
Why?
|
Hepatocytes | 1 | 2006 | 1211 | 0.040 |
Why?
|
Electroretinography | 1 | 2000 | 509 | 0.040 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2006 | 380 | 0.040 |
Why?
|
Homeodomain Proteins | 2 | 1998 | 2418 | 0.040 |
Why?
|
Cell Movement | 5 | 2016 | 5218 | 0.040 |
Why?
|
Chromosomes, Human, 21-22 and Y | 3 | 1975 | 46 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2015 | 6539 | 0.040 |
Why?
|
Vibrio cholerae | 1 | 2005 | 807 | 0.040 |
Why?
|
Computational Biology | 2 | 2009 | 3519 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2000 | 373 | 0.040 |
Why?
|
Ribosomal Proteins | 1 | 2000 | 360 | 0.040 |
Why?
|
DNA, Mitochondrial | 2 | 2014 | 817 | 0.040 |
Why?
|
Gene Frequency | 3 | 2015 | 3587 | 0.040 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2013 | 555 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 491 | 0.040 |
Why?
|
Drug Resistance | 4 | 1986 | 1608 | 0.040 |
Why?
|
Age of Onset | 3 | 2015 | 3270 | 0.040 |
Why?
|
Diet | 5 | 2008 | 7937 | 0.040 |
Why?
|
Fetal Death | 2 | 2000 | 448 | 0.040 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1999 | 402 | 0.040 |
Why?
|
Narcolepsy | 1 | 2000 | 195 | 0.040 |
Why?
|
Clone Cells | 16 | 1998 | 1692 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 871 | 0.040 |
Why?
|
Pregnancy | 3 | 2010 | 29144 | 0.040 |
Why?
|
DNA Fingerprinting | 1 | 1997 | 112 | 0.040 |
Why?
|
Genes, Essential | 1 | 1998 | 183 | 0.040 |
Why?
|
Leukemia | 2 | 1997 | 1510 | 0.040 |
Why?
|
Catenins | 1 | 1997 | 41 | 0.040 |
Why?
|
Chromosome Inversion | 1 | 1997 | 127 | 0.040 |
Why?
|
Reference Values | 2 | 2009 | 4982 | 0.040 |
Why?
|
Dermatan Sulfate | 1 | 1996 | 35 | 0.040 |
Why?
|
Adolescent | 12 | 2015 | 85779 | 0.040 |
Why?
|
Microscopy, Fluorescence | 2 | 2003 | 2700 | 0.040 |
Why?
|
Telomere | 2 | 2001 | 910 | 0.040 |
Why?
|
Lung | 4 | 2013 | 9857 | 0.040 |
Why?
|
Neuropsychological Tests | 2 | 2007 | 6994 | 0.040 |
Why?
|
Plasmacytoma | 1 | 1978 | 183 | 0.040 |
Why?
|
Tumor Stem Cell Assay | 1 | 2016 | 118 | 0.040 |
Why?
|
Kinetics | 3 | 2011 | 6476 | 0.040 |
Why?
|
Family | 1 | 2008 | 3147 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2015 | 21748 | 0.040 |
Why?
|
Retinal Diseases | 2 | 2000 | 684 | 0.040 |
Why?
|
Heart Neoplasms | 1 | 2000 | 374 | 0.040 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 1998 | 168 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2012 | 6036 | 0.040 |
Why?
|
Systems Integration | 2 | 1995 | 440 | 0.040 |
Why?
|
Brain Chemistry | 1 | 2000 | 982 | 0.040 |
Why?
|
Models, Biological | 3 | 2013 | 9584 | 0.040 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 1996 | 136 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3524 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2007 | 7914 | 0.040 |
Why?
|
Neurofibromatosis 1 | 1 | 2002 | 570 | 0.040 |
Why?
|
Melanins | 1 | 1998 | 289 | 0.040 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1997 | 245 | 0.030 |
Why?
|
Eye Proteins | 1 | 2000 | 645 | 0.030 |
Why?
|
Child | 13 | 2014 | 77709 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2016 | 3554 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2003 | 1026 | 0.030 |
Why?
|
Sequence Alignment | 5 | 2000 | 2256 | 0.030 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2016 | 42 | 0.030 |
Why?
|
Local Area Networks | 1 | 1995 | 11 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 2 | 2002 | 1097 | 0.030 |
Why?
|
Time Factors | 8 | 2009 | 40075 | 0.030 |
Why?
|
Neomycin | 2 | 1986 | 88 | 0.030 |
Why?
|
Child, Preschool | 9 | 2009 | 41005 | 0.030 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2016 | 80 | 0.030 |
Why?
|
Calcium Channels | 1 | 2000 | 622 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2009 | 11726 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2001 | 365 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3528 | 0.030 |
Why?
|
Myogenic Regulatory Factors | 1 | 1996 | 106 | 0.030 |
Why?
|
Cell Fusion | 4 | 1983 | 297 | 0.030 |
Why?
|
Epithelium, Corneal | 1 | 1998 | 247 | 0.030 |
Why?
|
Cell Nucleus | 3 | 2012 | 2969 | 0.030 |
Why?
|
Protein Transport | 2 | 2013 | 1988 | 0.030 |
Why?
|
Maze Learning | 2 | 2011 | 478 | 0.030 |
Why?
|
Crossing Over, Genetic | 1 | 1995 | 95 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3508 | 0.030 |
Why?
|
Hippocampus | 2 | 2005 | 3675 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1996 | 323 | 0.030 |
Why?
|
Kyphosis | 1 | 1997 | 237 | 0.030 |
Why?
|
Gene Conversion | 2 | 1985 | 71 | 0.030 |
Why?
|
Tongue | 1 | 1998 | 406 | 0.030 |
Why?
|
Software Design | 1 | 1995 | 176 | 0.030 |
Why?
|
Tumor Cells, Cultured | 4 | 2002 | 6313 | 0.030 |
Why?
|
Autoradiography | 1 | 1996 | 745 | 0.030 |
Why?
|
Body Weight | 3 | 2008 | 4671 | 0.030 |
Why?
|
Adenylate Kinase | 1 | 2015 | 99 | 0.030 |
Why?
|
Triose-Phosphate Isomerase | 1 | 1975 | 44 | 0.030 |
Why?
|
Connecticut | 1 | 1995 | 366 | 0.030 |
Why?
|
Brain Neoplasms | 2 | 2013 | 8861 | 0.030 |
Why?
|
Data Display | 1 | 1995 | 182 | 0.030 |
Why?
|
Genes, Reporter | 3 | 2008 | 1547 | 0.030 |
Why?
|
Cerebral Cortex | 2 | 2009 | 5709 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2001 | 3702 | 0.030 |
Why?
|
Liver | 4 | 2006 | 7475 | 0.030 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2017 | 434 | 0.030 |
Why?
|
Duodenum | 3 | 2003 | 484 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1996 | 403 | 0.030 |
Why?
|
Synteny | 2 | 2006 | 79 | 0.030 |
Why?
|
Central Nervous System | 2 | 2003 | 1357 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 2 | 2008 | 295 | 0.030 |
Why?
|
Craniofacial Abnormalities | 1 | 1997 | 315 | 0.030 |
Why?
|
Heredity | 1 | 2015 | 154 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2014 | 98 | 0.030 |
Why?
|
Neuropeptides | 1 | 2000 | 942 | 0.030 |
Why?
|
Cell Lineage | 3 | 2013 | 2504 | 0.030 |
Why?
|
Epidermolysis Bullosa Simplex | 1 | 1994 | 13 | 0.030 |
Why?
|
New Zealand | 1 | 2015 | 355 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2016 | 677 | 0.030 |
Why?
|
Ophthalmoplegia | 1 | 1995 | 166 | 0.030 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 1996 | 139 | 0.030 |
Why?
|
Immunoglobulins | 1 | 1978 | 881 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5181 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2005 | 3084 | 0.030 |
Why?
|
Purkinje Cells | 1 | 1996 | 224 | 0.030 |
Why?
|
DNA Glycosylases | 1 | 2015 | 128 | 0.030 |
Why?
|
Methods | 2 | 1990 | 1129 | 0.030 |
Why?
|
Cell-Free System | 2 | 1985 | 344 | 0.030 |
Why?
|
Helicobacter Infections | 1 | 1997 | 387 | 0.030 |
Why?
|
DNA, Satellite | 1 | 1994 | 69 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2015 | 367 | 0.030 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 1997 | 404 | 0.030 |
Why?
|
Cohort Studies | 6 | 2019 | 40559 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2000 | 804 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 315 | 0.030 |
Why?
|
Arm | 1 | 1997 | 589 | 0.030 |
Why?
|
Organizational Objectives | 1 | 1995 | 438 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2000 | 1423 | 0.030 |
Why?
|
Pharynx | 1 | 1996 | 413 | 0.030 |
Why?
|
Chemoprevention | 1 | 1996 | 319 | 0.030 |
Why?
|
Factor IX | 1 | 1993 | 77 | 0.030 |
Why?
|
New York City | 1 | 1995 | 710 | 0.030 |
Why?
|
Microtubules | 1 | 1979 | 1089 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3922 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2001 | 5974 | 0.030 |
Why?
|
Hematopoiesis | 2 | 2005 | 2073 | 0.030 |
Why?
|
Corneal Diseases | 1 | 2000 | 636 | 0.030 |
Why?
|
Optic Nerve | 1 | 1996 | 554 | 0.030 |
Why?
|
Chromosomes, Human, 4-5 | 3 | 1980 | 28 | 0.030 |
Why?
|
alpha-L-Fucosidase | 3 | 1978 | 8 | 0.030 |
Why?
|
Infant | 5 | 2014 | 35134 | 0.030 |
Why?
|
Alternative Splicing | 2 | 2008 | 1117 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 658 | 0.030 |
Why?
|
Quinazolines | 2 | 2011 | 1356 | 0.030 |
Why?
|
Glycine | 2 | 2008 | 671 | 0.030 |
Why?
|
RNA | 4 | 2003 | 2749 | 0.030 |
Why?
|
Virus Integration | 1 | 2014 | 299 | 0.030 |
Why?
|
Growth Disorders | 1 | 1997 | 645 | 0.030 |
Why?
|
DNA Polymerase II | 1 | 2013 | 107 | 0.030 |
Why?
|
Electric Stimulation | 2 | 2005 | 1767 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 2 | 2013 | 2305 | 0.030 |
Why?
|
Soft Tissue Neoplasms | 1 | 2002 | 1363 | 0.030 |
Why?
|
Esophagus | 1 | 1998 | 1019 | 0.030 |
Why?
|
Cytokines | 1 | 2007 | 7323 | 0.030 |
Why?
|
HT29 Cells | 1 | 2012 | 200 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2005 | 3057 | 0.030 |
Why?
|
Genetics | 1 | 1993 | 112 | 0.030 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1998 | 834 | 0.030 |
Why?
|
Staining and Labeling | 3 | 1976 | 1101 | 0.030 |
Why?
|
Retina | 2 | 2000 | 2616 | 0.030 |
Why?
|
Genes, Immediate-Early | 2 | 2003 | 101 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 713 | 0.030 |
Why?
|
Oxazolone | 1 | 2011 | 60 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2003 | 2148 | 0.030 |
Why?
|
Australia | 1 | 2015 | 1167 | 0.030 |
Why?
|
Mice, Congenic | 1 | 2011 | 99 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2009 | 1284 | 0.030 |
Why?
|
Spinal Cord | 2 | 1998 | 1810 | 0.030 |
Why?
|
Carcinogens | 2 | 2005 | 466 | 0.030 |
Why?
|
Cornea | 1 | 2000 | 1524 | 0.030 |
Why?
|
Computer Simulation | 3 | 2015 | 6194 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2018 | 1340 | 0.030 |
Why?
|
Selection, Genetic | 2 | 2002 | 914 | 0.030 |
Why?
|
Cognition | 2 | 2006 | 6770 | 0.020 |
Why?
|
Biotechnology | 1 | 1993 | 281 | 0.020 |
Why?
|
Reproduction | 1 | 1996 | 668 | 0.020 |
Why?
|
Vocalization, Animal | 1 | 2011 | 87 | 0.020 |
Why?
|
Oocytes | 1 | 1996 | 1188 | 0.020 |
Why?
|
Myosins | 1 | 1992 | 409 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2012 | 418 | 0.020 |
Why?
|
Karyotyping | 4 | 2005 | 1243 | 0.020 |
Why?
|
Breeding | 1 | 2010 | 51 | 0.020 |
Why?
|
Leiomyoma | 1 | 1996 | 730 | 0.020 |
Why?
|
Neuroendocrine Cells | 1 | 2011 | 61 | 0.020 |
Why?
|
Fetus | 2 | 1997 | 1880 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 1996 | 1463 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2014 | 15160 | 0.020 |
Why?
|
Ultrasonics | 1 | 2011 | 212 | 0.020 |
Why?
|
Muscle Proteins | 1 | 1996 | 1158 | 0.020 |
Why?
|
Linkage Disequilibrium | 2 | 2006 | 1997 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2012 | 338 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1683 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 496 | 0.020 |
Why?
|
Neurosciences | 1 | 1995 | 348 | 0.020 |
Why?
|
Endometrium | 2 | 2003 | 424 | 0.020 |
Why?
|
Middle Aged | 13 | 2015 | 213390 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2011 | 367 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1783 | 0.020 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 1996 | 852 | 0.020 |
Why?
|
Nomograms | 1 | 2011 | 228 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2012 | 612 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 1999 | 1703 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 528 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 4 | 1977 | 871 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2065 | 0.020 |
Why?
|
Maryland | 1 | 1990 | 276 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 1995 | 1115 | 0.020 |
Why?
|
MSX1 Transcription Factor | 1 | 2009 | 53 | 0.020 |
Why?
|
Transcriptional Activation | 2 | 2008 | 1783 | 0.020 |
Why?
|
Intestines | 1 | 1999 | 1924 | 0.020 |
Why?
|
Benzimidazoles | 1 | 1975 | 850 | 0.020 |
Why?
|
Gene Duplication | 2 | 2001 | 329 | 0.020 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 1989 | 47 | 0.020 |
Why?
|
Electron Transport Complex IV | 1 | 2009 | 189 | 0.020 |
Why?
|
Fibroblast Growth Factor 8 | 1 | 2009 | 61 | 0.020 |
Why?
|
Genomic Library | 1 | 2009 | 193 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11126 | 0.020 |
Why?
|
Decorin | 2 | 2000 | 40 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2010 | 562 | 0.020 |
Why?
|
Cytochromes c | 1 | 2009 | 180 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2010 | 279 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 1990 | 462 | 0.020 |
Why?
|
Sarcoma | 2 | 1997 | 1897 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4751 | 0.020 |
Why?
|
Carcinogenicity Tests | 1 | 2008 | 41 | 0.020 |
Why?
|
Anisotropy | 1 | 2012 | 1265 | 0.020 |
Why?
|
Goosecoid Protein | 2 | 1998 | 9 | 0.020 |
Why?
|
Codon | 2 | 2004 | 611 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2011 | 689 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2002 | 3854 | 0.020 |
Why?
|
User-Computer Interface | 1 | 1995 | 1431 | 0.020 |
Why?
|
Aged | 11 | 2015 | 163288 | 0.020 |
Why?
|
Filtration | 1 | 2009 | 234 | 0.020 |
Why?
|
Leukocytes | 1 | 1997 | 2045 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3616 | 0.020 |
Why?
|
Ethylnitrosourea | 1 | 2008 | 51 | 0.020 |
Why?
|
Risk Factors | 6 | 2015 | 72296 | 0.020 |
Why?
|
Mitochondrial Membranes | 1 | 2009 | 174 | 0.020 |
Why?
|
Introns | 2 | 2002 | 992 | 0.020 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2008 | 56 | 0.020 |
Why?
|
TRPP Cation Channels | 2 | 2000 | 176 | 0.020 |
Why?
|
Deoxyribonucleoproteins | 1 | 1987 | 3 | 0.020 |
Why?
|
Nucleic Acid Renaturation | 1 | 1987 | 11 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2009 | 408 | 0.020 |
Why?
|
Lac Operon | 1 | 2008 | 238 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2014 | 11031 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2014 | 9274 | 0.020 |
Why?
|
Leucovorin | 1 | 2009 | 628 | 0.020 |
Why?
|
Open Reading Frames | 2 | 2005 | 811 | 0.020 |
Why?
|
Models, Neurological | 2 | 2009 | 1775 | 0.020 |
Why?
|
COS Cells | 1 | 2009 | 1161 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2008 | 194 | 0.020 |
Why?
|
Brain Mapping | 3 | 2012 | 6670 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2010 | 365 | 0.020 |
Why?
|
Oxidative Phosphorylation | 1 | 2009 | 481 | 0.020 |
Why?
|
Radiation, Ionizing | 1 | 2008 | 258 | 0.020 |
Why?
|
Molecular Weight | 2 | 1980 | 2255 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2012 | 721 | 0.020 |
Why?
|
Models, Animal | 2 | 2005 | 2173 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2043 | 0.020 |
Why?
|
Transcription, Genetic | 4 | 2003 | 7721 | 0.020 |
Why?
|
Carcinoma | 3 | 1998 | 2375 | 0.020 |
Why?
|
Hypokinesia | 1 | 2006 | 17 | 0.020 |
Why?
|
Tryptophan-tRNA Ligase | 2 | 1976 | 17 | 0.020 |
Why?
|
Immunity, Mucosal | 1 | 2010 | 490 | 0.020 |
Why?
|
Phosphorylation | 2 | 2009 | 8436 | 0.020 |
Why?
|
Carbon Tetrachloride Poisoning | 1 | 2006 | 13 | 0.020 |
Why?
|
Disaccharidases | 2 | 1976 | 18 | 0.020 |
Why?
|
Short Interspersed Nucleotide Elements | 1 | 2006 | 40 | 0.020 |
Why?
|
Adenosine Kinase | 2 | 1976 | 12 | 0.020 |
Why?
|
Microscopy | 1 | 2011 | 902 | 0.020 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2006 | 129 | 0.020 |
Why?
|
Wechsler Scales | 1 | 2006 | 260 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2009 | 1137 | 0.020 |
Why?
|
Hydrostatic Pressure | 1 | 2006 | 106 | 0.020 |
Why?
|
Cloning, Organism | 1 | 2006 | 54 | 0.020 |
Why?
|
Immune System | 1 | 2011 | 806 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12746 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2011 | 2726 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 1997 | 1832 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 1997 | 318 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1997 | 5524 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2006 | 229 | 0.020 |
Why?
|
Inflammation | 3 | 2011 | 10637 | 0.020 |
Why?
|
Kidney | 4 | 1998 | 7184 | 0.020 |
Why?
|
Tubulin | 2 | 1999 | 695 | 0.020 |
Why?
|
Software Validation | 1 | 2005 | 59 | 0.020 |
Why?
|
Young Adult | 4 | 2015 | 56429 | 0.020 |
Why?
|
Rats | 3 | 2013 | 24252 | 0.020 |
Why?
|
Gentamicins | 1 | 1986 | 255 | 0.020 |
Why?
|
Base Pairing | 1 | 2005 | 141 | 0.020 |
Why?
|
Antigens, Viral | 2 | 1980 | 1035 | 0.020 |
Why?
|
Amino Acyl-tRNA Synthetases | 2 | 1976 | 93 | 0.020 |
Why?
|
Amphetamines | 1 | 2005 | 148 | 0.020 |
Why?
|
Velopharyngeal Insufficiency | 1 | 2006 | 87 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2006 | 270 | 0.020 |
Why?
|
Protein Conformation | 3 | 2002 | 4010 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2005 | 300 | 0.020 |
Why?
|
Histones | 1 | 1995 | 2598 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1707 | 0.020 |
Why?
|
Fluorouracil | 1 | 2009 | 1619 | 0.020 |
Why?
|
Sex Chromosomes | 2 | 2002 | 105 | 0.020 |
Why?
|
Tissue Distribution | 2 | 2000 | 2327 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 2 | 2000 | 850 | 0.020 |
Why?
|
Malate Dehydrogenase | 2 | 1974 | 41 | 0.020 |
Why?
|
Replicon | 1 | 1984 | 34 | 0.020 |
Why?
|
Lod Score | 2 | 1995 | 614 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 2005 | 425 | 0.020 |
Why?
|
Valine | 1 | 2006 | 413 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 2 | 1989 | 2249 | 0.020 |
Why?
|
Embryonic Development | 1 | 2009 | 711 | 0.020 |
Why?
|
Yeasts | 1 | 2005 | 284 | 0.020 |
Why?
|
Age Factors | 2 | 1999 | 18373 | 0.010 |
Why?
|
Cricetulus | 1 | 1986 | 818 | 0.010 |
Why?
|
Isoenzymes | 3 | 1999 | 1728 | 0.010 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2005 | 377 | 0.010 |
Why?
|
Histocompatibility Antigens | 2 | 1976 | 471 | 0.010 |
Why?
|
Chromosome Disorders | 2 | 1997 | 514 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2011 | 1425 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2005 | 876 | 0.010 |
Why?
|
Neurons, Afferent | 1 | 2006 | 506 | 0.010 |
Why?
|
Random Allocation | 1 | 2008 | 2428 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2513 | 0.010 |
Why?
|
Immunoassay | 1 | 2007 | 752 | 0.010 |
Why?
|
Tumor Burden | 1 | 2009 | 1915 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2924 | 0.010 |
Why?
|
Diethylstilbestrol | 1 | 2003 | 93 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 2005 | 455 | 0.010 |
Why?
|
Methionine | 1 | 2006 | 590 | 0.010 |
Why?
|
Testis | 2 | 1998 | 804 | 0.010 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2003 | 95 | 0.010 |
Why?
|
Oncogenes | 2 | 2002 | 1265 | 0.010 |
Why?
|
Membrane Transport Proteins | 1 | 2009 | 1031 | 0.010 |
Why?
|
In Situ Hybridization | 2 | 1998 | 1950 | 0.010 |
Why?
|
Drug Resistance, Microbial | 1 | 1986 | 862 | 0.010 |
Why?
|
Haplorhini | 1 | 1984 | 552 | 0.010 |
Why?
|
Azoxymethane | 1 | 2002 | 36 | 0.010 |
Why?
|
Cell Cycle | 2 | 2003 | 2967 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19905 | 0.010 |
Why?
|
MyoD Protein | 1 | 2003 | 151 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 25039 | 0.010 |
Why?
|
MutS DNA Mismatch-Binding Protein | 1 | 2002 | 11 | 0.010 |
Why?
|
Nociceptors | 1 | 2006 | 432 | 0.010 |
Why?
|
Operon | 1 | 1983 | 363 | 0.010 |
Why?
|
Pseudogenes | 1 | 2002 | 113 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2005 | 596 | 0.010 |
Why?
|
Mesoderm | 1 | 2006 | 686 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2890 | 0.010 |
Why?
|
Sex Factors | 2 | 2007 | 10400 | 0.010 |
Why?
|
Keratinocytes | 2 | 1999 | 799 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3848 | 0.010 |
Why?
|
Buffers | 1 | 2002 | 147 | 0.010 |
Why?
|
PPAR gamma | 1 | 2005 | 493 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 1982 | 322 | 0.010 |
Why?
|
Clozapine | 1 | 2005 | 498 | 0.010 |
Why?
|
Aging | 2 | 1998 | 8664 | 0.010 |
Why?
|
Mucin-2 | 1 | 2002 | 49 | 0.010 |
Why?
|
Corpus Striatum | 1 | 2008 | 1221 | 0.010 |
Why?
|
S Phase | 1 | 2003 | 423 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3505 | 0.010 |
Why?
|
Inbreeding | 1 | 2001 | 49 | 0.010 |
Why?
|
Insulin | 2 | 2009 | 6582 | 0.010 |
Why?
|
Tandem Mass Spectrometry | 1 | 2008 | 1157 | 0.010 |
Why?
|
Response Elements | 1 | 2003 | 312 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2076 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2001 | 122 | 0.010 |
Why?
|
Aneuploidy | 1 | 2005 | 530 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 2006 | 780 | 0.010 |
Why?
|
Genes, erbB-2 | 1 | 2002 | 162 | 0.010 |
Why?
|
Duodenal Neoplasms | 1 | 2002 | 106 | 0.010 |
Why?
|
Colitis | 1 | 2010 | 1170 | 0.010 |
Why?
|
Periodicals as Topic | 1 | 1993 | 1431 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1295 | 0.010 |
Why?
|
Alanine | 1 | 2004 | 572 | 0.010 |
Why?
|
GC Rich Sequence | 1 | 2001 | 21 | 0.010 |
Why?
|
Binding Sites | 2 | 2003 | 6111 | 0.010 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2002 | 261 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2001 | 65 | 0.010 |
Why?
|
Motor Neurons | 1 | 2006 | 844 | 0.010 |
Why?
|
Dinucleotide Repeats | 1 | 2000 | 30 | 0.010 |
Why?
|
Kidney Tubules | 1 | 2003 | 488 | 0.010 |
Why?
|
Azacitidine | 1 | 1982 | 347 | 0.010 |
Why?
|
Melanosomes | 1 | 2000 | 31 | 0.010 |
Why?
|
Protein Biosynthesis | 2 | 2000 | 2126 | 0.010 |
Why?
|
Genes, fos | 1 | 2001 | 183 | 0.010 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2000 | 23 | 0.010 |
Why?
|
Genes, myc | 1 | 2002 | 399 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2013 | 20824 | 0.010 |
Why?
|
Bacteria | 1 | 1991 | 2115 | 0.010 |
Why?
|
Galactokinase | 1 | 1980 | 16 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 1 | 2000 | 29 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12356 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 2 | 2000 | 1988 | 0.010 |
Why?
|
Chromosomes, Artificial | 1 | 2000 | 3 | 0.010 |
Why?
|
Gene Order | 1 | 2000 | 176 | 0.010 |
Why?
|
Protein Phosphatase 2 | 1 | 2002 | 229 | 0.010 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2000 | 143 | 0.010 |
Why?
|
Tumor Virus Infections | 1 | 1983 | 454 | 0.010 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2000 | 57 | 0.010 |
Why?
|
Blood Vessels | 1 | 2006 | 1125 | 0.010 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2001 | 285 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2383 | 0.010 |
Why?
|
Bacteriophage P1 | 1 | 1999 | 10 | 0.010 |
Why?
|
Adenoviridae | 2 | 1975 | 1101 | 0.010 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1980 | 189 | 0.010 |
Why?
|
Autistic Disorder | 1 | 2009 | 1185 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1989 | 6621 | 0.010 |
Why?
|
Massachusetts | 1 | 2012 | 8662 | 0.010 |
Why?
|
Founder Effect | 1 | 2000 | 189 | 0.010 |
Why?
|
HLA Antigens | 2 | 1976 | 1382 | 0.010 |
Why?
|
Sebaceous Glands | 1 | 1999 | 41 | 0.010 |
Why?
|
Public Sector | 1 | 2001 | 265 | 0.010 |
Why?
|
Pons | 1 | 2000 | 245 | 0.010 |
Why?
|
Genitalia, Male | 1 | 1999 | 84 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5953 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8319 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2006 | 1953 | 0.010 |
Why?
|
Trisomy | 1 | 2000 | 266 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2005 | 1178 | 0.010 |
Why?
|
Hydrolysis | 1 | 2000 | 682 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15078 | 0.010 |
Why?
|
Goblet Cells | 1 | 2002 | 287 | 0.010 |
Why?
|
RNA, Untranslated | 1 | 2002 | 453 | 0.010 |
Why?
|
RNA Probes | 1 | 1998 | 113 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1793 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2000 | 437 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1999 | 378 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2005 | 2027 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 1994 | 1381 | 0.010 |
Why?
|
Glass | 1 | 1999 | 114 | 0.010 |
Why?
|
Optic Chiasm | 1 | 1998 | 87 | 0.010 |
Why?
|
Leucine | 1 | 2000 | 560 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10943 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 1999 | 644 | 0.010 |
Why?
|
Food, Fortified | 1 | 1999 | 191 | 0.010 |
Why?
|
Rabbits | 1 | 2005 | 4894 | 0.010 |
Why?
|
Urease | 1 | 1997 | 42 | 0.010 |
Why?
|
Caspase 3 | 1 | 2000 | 758 | 0.010 |
Why?
|
Chromosome Banding | 1 | 1997 | 278 | 0.010 |
Why?
|
Diarrhea | 1 | 2005 | 1348 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2000 | 906 | 0.010 |
Why?
|
Private Sector | 1 | 2001 | 392 | 0.010 |
Why?
|
Insect Proteins | 1 | 1999 | 258 | 0.010 |
Why?
|
Asthma | 1 | 1996 | 6010 | 0.010 |
Why?
|
Neural Inhibition | 1 | 2002 | 602 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5181 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3486 | 0.010 |
Why?
|
Leukemia, Lymphoid | 1 | 1978 | 315 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1998 | 719 | 0.010 |
Why?
|
Spermatogenesis | 1 | 1998 | 262 | 0.010 |
Why?
|
Helicobacter | 1 | 1997 | 112 | 0.010 |
Why?
|
Aged, 80 and over | 4 | 2011 | 57776 | 0.010 |
Why?
|
Biglycan | 1 | 1996 | 9 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1980 | 709 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2004 | 1782 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2009 | 35425 | 0.010 |
Why?
|
Mental Disorders | 1 | 1997 | 6598 | 0.010 |
Why?
|
West Indies | 1 | 1996 | 34 | 0.010 |
Why?
|
Caspases | 1 | 2000 | 928 | 0.010 |
Why?
|
Intermediate Filament Proteins | 1 | 1998 | 269 | 0.010 |
Why?
|
Radiation | 1 | 1996 | 49 | 0.010 |
Why?
|
Galactose | 2 | 1975 | 306 | 0.010 |
Why?
|
Dysthymic Disorder | 1 | 1996 | 74 | 0.010 |
Why?
|
Infertility, Male | 1 | 2000 | 409 | 0.010 |
Why?
|
Azure Stains | 1 | 1976 | 5 | 0.010 |
Why?
|
Models, Statistical | 1 | 2011 | 5101 | 0.010 |
Why?
|
Activin Receptors | 1 | 1996 | 43 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 2000 | 647 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 1996 | 319 | 0.010 |
Why?
|
Memory | 1 | 2006 | 2174 | 0.010 |
Why?
|
Rectum | 1 | 2001 | 904 | 0.010 |
Why?
|
Anticoagulants | 1 | 2011 | 4600 | 0.010 |
Why?
|
Activating Transcription Factor 1 | 1 | 1996 | 26 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2002 | 988 | 0.010 |
Why?
|
Phenothiazines | 1 | 1976 | 63 | 0.010 |
Why?
|
Glucose-6-Phosphate Isomerase | 1 | 1976 | 52 | 0.010 |
Why?
|
Myogenic Regulatory Factor 5 | 1 | 1996 | 25 | 0.010 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 1976 | 68 | 0.010 |
Why?
|
Motor Activity | 1 | 2006 | 2715 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 4042 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 1976 | 184 | 0.010 |
Why?
|
Polyps | 1 | 1997 | 189 | 0.010 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1996 | 70 | 0.010 |
Why?
|
Atrophy | 1 | 2000 | 1584 | 0.010 |
Why?
|
Hybridization, Genetic | 1 | 1975 | 109 | 0.010 |
Why?
|
Prevalence | 1 | 2012 | 15221 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2002 | 1121 | 0.010 |
Why?
|
Dietary Fiber | 1 | 1999 | 760 | 0.010 |
Why?
|
Temperature | 1 | 2002 | 2204 | 0.010 |
Why?
|
Lipidoses | 1 | 1975 | 10 | 0.010 |
Why?
|
Nuclear Family | 1 | 1996 | 318 | 0.010 |
Why?
|
Thiazoles | 1 | 2002 | 1483 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1976 | 919 | 0.010 |
Why?
|
High Mobility Group Proteins | 1 | 1996 | 187 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1975 | 326 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1979 | 2505 | 0.010 |
Why?
|
Chick Embryo | 1 | 1996 | 982 | 0.010 |
Why?
|
Hypothalamus | 1 | 2000 | 1063 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5172 | 0.010 |
Why?
|
Dwarfism | 1 | 1996 | 146 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2002 | 2019 | 0.010 |
Why?
|
Blood Glucose | 1 | 2009 | 6254 | 0.010 |
Why?
|
Biological Evolution | 2 | 1997 | 1077 | 0.010 |
Why?
|
Lasers | 1 | 1999 | 952 | 0.010 |
Why?
|
Adenoviridae Infections | 1 | 1975 | 96 | 0.010 |
Why?
|
Liposarcoma, Myxoid | 1 | 1994 | 67 | 0.010 |
Why?
|
Enzymes | 1 | 1976 | 266 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2646 | 0.010 |
Why?
|
RNA, Viral | 1 | 1982 | 2901 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 12262 | 0.010 |
Why?
|
Infertility, Female | 1 | 2000 | 788 | 0.010 |
Why?
|
Cysts | 1 | 1999 | 678 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 23336 | 0.010 |
Why?
|
Intermediate Filaments | 1 | 1994 | 175 | 0.010 |
Why?
|
Glycosylation | 1 | 1996 | 1128 | 0.010 |
Why?
|
Organ Size | 1 | 1998 | 2251 | 0.010 |
Why?
|
Blastocyst | 1 | 1996 | 424 | 0.010 |
Why?
|
Spleen | 1 | 1999 | 2362 | 0.010 |
Why?
|
Leukemia, Myeloid | 1 | 1996 | 707 | 0.010 |
Why?
|
Ribonucleoproteins | 1 | 1996 | 381 | 0.010 |
Why?
|
Protein Binding | 1 | 2005 | 9384 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 1975 | 741 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2000 | 1222 | 0.010 |
Why?
|
Melanoma | 2 | 1983 | 5511 | 0.010 |
Why?
|
Cartilage | 1 | 1996 | 818 | 0.010 |
Why?
|
Antibody Formation | 1 | 1997 | 1402 | 0.010 |
Why?
|
Virus Replication | 2 | 1978 | 2535 | 0.010 |
Why?
|
Information Systems | 1 | 1995 | 410 | 0.010 |
Why?
|
Heterochromatin | 1 | 1975 | 296 | 0.010 |
Why?
|
Receptors, Notch | 1 | 1996 | 739 | 0.010 |
Why?
|
Corpus Callosum | 1 | 1996 | 737 | 0.010 |
Why?
|
Forecasting | 1 | 2001 | 2951 | 0.010 |
Why?
|
Collagen | 1 | 2000 | 2688 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 1997 | 1470 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 1997 | 3658 | 0.010 |
Why?
|
Robotics | 1 | 1999 | 899 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20130 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1994 | 1247 | 0.010 |
Why?
|
Skin Diseases | 1 | 1999 | 1066 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2008 | 10183 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2002 | 2873 | 0.010 |
Why?
|
Antigens | 1 | 1976 | 1466 | 0.010 |
Why?
|
Antigens, CD | 1 | 2000 | 4026 | 0.010 |
Why?
|
Enzyme Induction | 2 | 1984 | 475 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 1977 | 1801 | 0.010 |
Why?
|
Cytoplasm | 1 | 1974 | 1536 | 0.010 |
Why?
|
Fibrosis | 1 | 1995 | 2029 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15535 | 0.010 |
Why?
|
Anemia | 1 | 1997 | 1503 | 0.000 |
Why?
|
Cooperative Behavior | 1 | 1995 | 1504 | 0.000 |
Why?
|
Prospective Studies | 1 | 2011 | 53290 | 0.000 |
Why?
|
Lymphocytes | 1 | 1975 | 2617 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2014 | 77460 | 0.000 |
Why?
|
Myelodysplastic Syndromes | 1 | 1994 | 1352 | 0.000 |
Why?
|
Bone Marrow | 1 | 1994 | 2948 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1994 | 3476 | 0.000 |
Why?
|
Comorbidity | 1 | 1996 | 10388 | 0.000 |
Why?
|
Poly A | 1 | 1982 | 185 | 0.000 |
Why?
|
Nucleic Acid Denaturation | 1 | 1980 | 111 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2007 | 63107 | 0.000 |
Why?
|
Genes, Synthetic | 1 | 1980 | 90 | 0.000 |
Why?
|
Leukemia, Experimental | 1 | 1980 | 246 | 0.000 |
Why?
|
Genes, Regulator | 1 | 1980 | 378 | 0.000 |
Why?
|
Dimethyl Sulfoxide | 1 | 1980 | 249 | 0.000 |
Why?
|
Isoelectric Focusing | 1 | 1978 | 181 | 0.000 |
Why?
|
Immune Sera | 1 | 1978 | 641 | 0.000 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 1976 | 27 | 0.000 |
Why?
|
Chromosomes, Human, 19-20 | 1 | 1976 | 12 | 0.000 |
Why?
|
Electrophoresis | 1 | 1976 | 240 | 0.000 |
Why?
|
Nucleoside-Phosphate Kinase | 1 | 1975 | 23 | 0.000 |
Why?
|
Electrophoresis, Starch Gel | 1 | 1974 | 20 | 0.000 |
Why?
|
Immunogenetics | 1 | 1975 | 67 | 0.000 |
Why?
|
Precipitin Tests | 1 | 1976 | 829 | 0.000 |
Why?
|
Aminohydrolases | 1 | 1974 | 18 | 0.000 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1975 | 329 | 0.000 |
Why?
|
Mannose | 1 | 1975 | 124 | 0.000 |
Why?
|
Uridine Monophosphate | 1 | 1975 | 70 | 0.000 |
Why?
|
Alcohol Oxidoreductases | 1 | 1974 | 170 | 0.000 |
Why?
|
Transaminases | 1 | 1974 | 200 | 0.000 |
Why?
|